Studies showed that the genetic modification of probiotics to generate anti-inflammatory cytokines including IL-10 or IL-35, successfully regulates inflammatory bowel disease (IBD) along with enhancing the restoration of immune equilibrium [32, 244–250]. The gene discussed is IL10; the disease is inflammatory bowel disease.